FDA Approved: PIRFENIDONE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

Camber Pharmaceuticals received FDA approval for a generic pirfenidone product via an Original Application (ANDA) to treat idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

ORIG AP for PIRFENIDONE (PIRFENIDONE)